Valuation: Sunrest Lifescience Limited

Market Cap 144M 1.51M 1.35M 1.25M 1.13M 2.12M 2.14M 14.97M 5.96M 75.22M 5.66M 5.54M 239M P/E 2025
11.5x
P/E 2026 3.86x
Enterprise Value 291M 3.05M 2.74M 2.53M 2.29M 4.28M 4.34M 30.27M 12.06M 152M 11.45M 11.21M 483M EV / Sales 2025
1x
EV / Sales 2026 0.43x
Free-Float
15.04%
Yield 2025 *
-
Yield 2026 -
1 day-4.29%
1 week-11.02%
Current month-11.84%
1 month-10.67%
3 months-4.29%
6 months-5.77%
Current year-19.37%
1 week 30.05
Extreme 30.05
33.5
1 month 30.05
Extreme 30.05
40.4
Current year 29.55
Extreme 29.55
50
1 year 29.55
Extreme 29.55
54
3 years 29.55
Extreme 29.55
84
5 years 29.55
Extreme 29.55
84
10 years 29.55
Extreme 29.55
84
Manager TitleAgeSince
Chief Executive Officer 42 2023-03-02
Director of Finance/CFO - 2023-02-28
Compliance Officer - 2026-01-15
Director TitleAgeSince
Chairman 30 2023-03-05
Director/Board Member 42 2017-10-29
Director/Board Member 44 2017-10-29
Change 5-day change 1-year change 3-year change Capi.($)
-4.29%-11.02%-20.24% - 1.51M
+0.54%+1.31%+56.99%+127.58% 1,143B
+0.64%+5.05%+44.87%+84.18% 647B
+0.43%+0.76%+26.12%+102.25% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-0.77%-6.10%+61.71%+37.07% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.38%+2.56%+53.92%+70.82% 242B
+0.19%+3.78%+35.20%+104.92% 197B
Average -0.31%+0.24%+34.49%+74.41% 402.75B
Weighted average by Cap. +0.24%+0.71%+44.44%+86.89%

Financials

2025 2026
Net sales 334M 3.51M 3.15M 2.91M 2.64M 4.92M 4.98M 34.79M 13.86M 175M 13.17M 12.89M 555M 708M 7.44M 6.67M 6.17M 5.59M 10.44M 10.56M 73.76M 29.38M 371M 27.91M 27.32M 1.18B
Net income 20.05M 211K 189K 175K 158K 296K 299K 2.09M 832K 10.49M 790K 773K 33.31M 41.16M 432K 388K 359K 325K 607K 614K 4.29M 1.71M 21.54M 1.62M 1.59M 68.38M
Net Debt 103M 1.08M 971K 898K 813K 1.52M 1.54M 10.74M 4.28M 53.96M 4.06M 3.98M 171M 147M 1.54M 1.38M 1.28M 1.16M 2.17M 2.19M 15.3M 6.09M 76.89M 5.79M 5.67M 244M
Projected Income Statement - Annual - Sunrest Lifescience Limited
Logo Sunrest Lifescience Limited
Sunrest Lifescience Limited is an India-based pharmaceutical company. The Company is engaged in the business of selling healthcare products, medicines and cosmetics. It focuses on all healthcare segments including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic and cosmetics. The Company's product portfolio consists of a comprehensive range of tablets, capsules, soft gels, syrups, dry syrups, injections, cream ointments and powders. Its anti-diabetic products include Glimrest M1 Tablet, Glimirest PM 2 Tablet, and others. Its skincare products include Ageshine Cream 30 gm, Calorest Lotion, Clinderest Gel, and others. The Company's subsidiary is Hetvi Lifesciences Private Limited, which is engaged in the manufacturing of healthcare products. The Company operates in different states of India, such as Maharashtra and Gujarat.
Employees
-
Date Price Change Volume
26-10-23 ₹33.50 -4.29% 4,800
  1. Stock Market
  2. Stocks
  3. SUNREST Stock